These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 24559392)
1. Oligonucleotides--assembled Au nanorod-assisted cancer photothermal ablation and combination chemotherapy with targeted dual-drug delivery of Doxorubicin and Cisplatin prodrug. Shanmugam V; Chien YH; Cheng YS; Liu TY; Huang CC; Su CH; Chen YS; Kumar U; Hsu HF; Yeh CS ACS Appl Mater Interfaces; 2014 Mar; 6(6):4382-93. PubMed ID: 24559392 [TBL] [Abstract][Full Text] [Related]
2. Platinum(IV) prodrug conjugated Pd@Au nanoplates for chemotherapy and photothermal therapy. Shi S; Chen X; Wei J; Huang Y; Weng J; Zheng N Nanoscale; 2016 Mar; 8(10):5706-13. PubMed ID: 26900670 [TBL] [Abstract][Full Text] [Related]
3. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849 [TBL] [Abstract][Full Text] [Related]
4. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery. Du C; Deng D; Shan L; Wan S; Cao J; Tian J; Achilefu S; Gu Y Biomaterials; 2013 Apr; 34(12):3087-97. PubMed ID: 23374705 [TBL] [Abstract][Full Text] [Related]
5. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects. Hernández-Gil J; Cobaleda-Siles M; Zabaleta A; Salassa L; Calvo J; Mareque-Rivas JC Adv Healthc Mater; 2015 May; 4(7):1034-42. PubMed ID: 25846677 [TBL] [Abstract][Full Text] [Related]
6. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes. Wen S; Liu H; Cai H; Shen M; Shi X Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549 [TBL] [Abstract][Full Text] [Related]
7. Pt(IV) Prodrugs Designed to Embed in Nanotubes of a Polysaccharide for Drug Delivery. Chen K; Cai L; Yang S; Peng S; Huang J; Xu J; Lu Z; Xu X; Fu B; Zhang L; Zhou X ACS Appl Bio Mater; 2021 Jun; 4(6):4841-4848. PubMed ID: 35007033 [TBL] [Abstract][Full Text] [Related]
8. Combating the drug resistance of cisplatin using a platinum prodrug based delivery system. Min Y; Mao CQ; Chen S; Ma G; Wang J; Liu Y Angew Chem Int Ed Engl; 2012 Jul; 51(27):6742-7. PubMed ID: 22639083 [No Abstract] [Full Text] [Related]
9. Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo. Nguyen VD; Min HK; Kim CS; Han J; Park JO; Choi E Colloids Surf B Biointerfaces; 2019 Jan; 173():539-548. PubMed ID: 30343218 [TBL] [Abstract][Full Text] [Related]
10. Combined chemo- and photo-thermal therapy delivered by multifunctional theranostic gold nanorod-loaded microcapsules. Chen H; Di Y; Chen D; Madrid K; Zhang M; Tian C; Tang L; Gu Y Nanoscale; 2015 May; 7(19):8884-97. PubMed ID: 25913201 [TBL] [Abstract][Full Text] [Related]
11. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777 [TBL] [Abstract][Full Text] [Related]
12. Dual Chemodrug-Loaded Single-Walled Carbon Nanohorns for Multimodal Imaging-Guided Chemo-Photothermal Therapy of Tumors and Lung Metastases. Yang J; Su H; Sun W; Cai J; Liu S; Chai Y; Zhang C Theranostics; 2018; 8(7):1966-1984. PubMed ID: 29556368 [TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of the biological properties of reducible and acid-sensitive folate prodrugs of a highly potent doxorubicin derivative. Abu Ajaj K; El-Abadla N; Welker P; Azab S; Zeisig R; Fichtner I; Kratz F Eur J Cancer; 2012 Sep; 48(13):2054-65. PubMed ID: 21937219 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy. Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314 [TBL] [Abstract][Full Text] [Related]
15. A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy. Li SY; Liu LH; Jia HZ; Qiu WX; Rong L; Cheng H; Zhang XZ Chem Commun (Camb); 2014 Oct; 50(80):11852-5. PubMed ID: 25145493 [TBL] [Abstract][Full Text] [Related]
16. A prodrug nanoassembly entrapping drugs as a tumor-targeted delivery system. Yuan Z; Yi X; Zhang J; Cheng S; Zhuo R; Li F Chem Commun (Camb); 2013 Jan; 49(8):801-3. PubMed ID: 23235958 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug. Huang S; Fang R; Xu J; Qiu S; Zhang H; Du J; Cai S J Drug Target; 2011 Aug; 19(7):487-96. PubMed ID: 21284542 [TBL] [Abstract][Full Text] [Related]
18. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity. Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289 [TBL] [Abstract][Full Text] [Related]
19. Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes. Lu YJ; Wei KC; Ma CC; Yang SY; Chen JP Colloids Surf B Biointerfaces; 2012 Jan; 89():1-9. PubMed ID: 21982868 [TBL] [Abstract][Full Text] [Related]
20. Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release. Li Y; Niu Y; Zhu J; Gao C; Xu Q; He Z; Chen D; Xu M; Liu Y Nanoscale; 2020 Jan; 12(4):2673-2685. PubMed ID: 31942900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]